433 related articles for article (PubMed ID: 30335249)
1. A new theory of depression based on the serotonin/kynurenine relationship and the hypothalamicpituitary- adrenal axis.
Ramírez LA; Pérez-Padilla EA; García-Oscos F; Salgado H; Atzori M; Pineda JC
Biomedica; 2018 Sep; 38(3):437-450. PubMed ID: 30335249
[TBL] [Abstract][Full Text] [Related]
2. A link between stress and depression: shifts in the balance between the kynurenine and serotonin pathways of tryptophan metabolism and the etiology and pathophysiology of depression.
Miura H; Ozaki N; Sawada M; Isobe K; Ohta T; Nagatsu T
Stress; 2008 May; 11(3):198-209. PubMed ID: 18465467
[TBL] [Abstract][Full Text] [Related]
3. The immune-mediated alteration of serotonin and glutamate: towards an integrated view of depression.
Müller N; Schwarz MJ
Mol Psychiatry; 2007 Nov; 12(11):988-1000. PubMed ID: 17457312
[TBL] [Abstract][Full Text] [Related]
4. [Depression and inflammation in rheumatic diseases].
Buras A; Waszkiewicz N; Szulc A
Postepy Hig Med Dosw (Online); 2016 Mar; 70():162-8. PubMed ID: 26943313
[TBL] [Abstract][Full Text] [Related]
5. The new '5-HT' hypothesis of depression: cell-mediated immune activation induces indoleamine 2,3-dioxygenase, which leads to lower plasma tryptophan and an increased synthesis of detrimental tryptophan catabolites (TRYCATs), both of which contribute to the onset of depression.
Maes M; Leonard BE; Myint AM; Kubera M; Verkerk R
Prog Neuropsychopharmacol Biol Psychiatry; 2011 Apr; 35(3):702-21. PubMed ID: 21185346
[TBL] [Abstract][Full Text] [Related]
6. Etiological classification of depression based on the enzymes of tryptophan metabolism.
Fukuda K
BMC Psychiatry; 2014 Dec; 14():372. PubMed ID: 25540092
[TBL] [Abstract][Full Text] [Related]
7. The HPA and immune axes in stress: the involvement of the serotonergic system.
Leonard BE
Eur Psychiatry; 2005 Oct; 20 Suppl 3():S302-6. PubMed ID: 16459240
[TBL] [Abstract][Full Text] [Related]
8. Chronic Mild Stress Alters Kynurenine Pathways Changing the Glutamate Neurotransmission in Frontal Cortex of Rats.
Martín-Hernández D; Tendilla-Beltrán H; Madrigal JLM; García-Bueno B; Leza JC; Caso JR
Mol Neurobiol; 2019 Jan; 56(1):490-501. PubMed ID: 29725904
[TBL] [Abstract][Full Text] [Related]
9. [New developments on the serotonin hypothesis of depression: shunt of tryptophan].
Marazziti D; Baroni S; Picchetti M; Piccinni A; Silvestri S; Dell'Osso L
Riv Psichiatr; 2013; 48(1):23-34. PubMed ID: 23438698
[TBL] [Abstract][Full Text] [Related]
10. Network beyond IDO in psychiatric disorders: revisiting neurodegeneration hypothesis.
Myint AM; Kim YK
Prog Neuropsychopharmacol Biol Psychiatry; 2014 Jan; 48():304-13. PubMed ID: 24184687
[TBL] [Abstract][Full Text] [Related]
11. The immune effects of TRYCATs (tryptophan catabolites along the IDO pathway): relevance for depression - and other conditions characterized by tryptophan depletion induced by inflammation.
Maes M; Mihaylova I; Ruyter MD; Kubera M; Bosmans E
Neuro Endocrinol Lett; 2007 Dec; 28(6):826-31. PubMed ID: 18063923
[TBL] [Abstract][Full Text] [Related]
12. Cytokine regulation of tryptophan metabolism in the hypothalamic-pituitary-adrenal (HPA) axis: implications for protective and toxic consequences in neuroendocrine regulation.
Tu H; Rady PL; Juelich T; Smith EM; Tyring SK; Hughes TK
Cell Mol Neurobiol; 2005 Jun; 25(3-4):673-80. PubMed ID: 16075385
[TBL] [Abstract][Full Text] [Related]
13. Kynurenine pathway metabolic balance influences microglia activity: Targeting kynurenine monooxygenase to dampen neuroinflammation.
Garrison AM; Parrott JM; Tuñon A; Delgado J; Redus L; O'Connor JC
Psychoneuroendocrinology; 2018 Aug; 94():1-10. PubMed ID: 29734055
[TBL] [Abstract][Full Text] [Related]
14. Tryptophan kynurenine metabolism as a common mediator of genetic and environmental impacts in major depressive disorder: the serotonin hypothesis revisited 40 years later.
Oxenkrug GF
Isr J Psychiatry Relat Sci; 2010; 47(1):56-63. PubMed ID: 20686200
[TBL] [Abstract][Full Text] [Related]
15. Indoleamine-2,3-Dioxygenase/Kynurenine Pathway as a Potential Pharmacological Target to Treat Depression Associated with Diabetes.
da Silva Dias IC; Carabelli B; Ishii DK; de Morais H; de Carvalho MC; Rizzo de Souza LE; Zanata SM; Brandão ML; Cunha TM; Ferraz AC; Cunha JM; Zanoveli JM
Mol Neurobiol; 2016 Dec; 53(10):6997-7009. PubMed ID: 26671617
[TBL] [Abstract][Full Text] [Related]
16. The kynurenine pathway activities in a sub-Saharan HIV/AIDS population.
Bipath P; Levay PF; Viljoen M
BMC Infect Dis; 2015 Aug; 15():346. PubMed ID: 26285873
[TBL] [Abstract][Full Text] [Related]
17. Inflammation, depression and cardiovascular disease in women: the role of the immune system across critical reproductive events.
Mattina GF; Van Lieshout RJ; Steiner M
Ther Adv Cardiovasc Dis; 2019; 13():1753944719851950. PubMed ID: 31144599
[TBL] [Abstract][Full Text] [Related]
18. Changes in the immune system in depression and dementia: causal or coincidental effects?
Leonard BE; Myint A
Dialogues Clin Neurosci; 2006; 8(2):163-74. PubMed ID: 16889103
[TBL] [Abstract][Full Text] [Related]
19. Role of the indoleamine-2,3-dioxygenase/kynurenine pathway of tryptophan metabolism in behavioral alterations in a hepatic encephalopathy rat model.
Jiang X; Xu L; Tang L; Liu F; Chen Z; Zhang J; Chen L; Pang C; Yu X
J Neuroinflammation; 2018 Jan; 15(1):3. PubMed ID: 29301550
[TBL] [Abstract][Full Text] [Related]
20. Targeting Oxidative Stress, Cytokines and Serotonin Interactions Via Indoleamine 2, 3 Dioxygenase by Coenzyme Q10: Role in Suppressing Depressive Like Behavior in Rats.
Abuelezz SA; Hendawy N; Magdy Y
J Neuroimmune Pharmacol; 2017 Jun; 12(2):277-291. PubMed ID: 27730347
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]